BJU International

Papers
(The H4-Index of BJU International is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Is Artificial Intelligence Ready for “Primetime” in Urology?80
Editorial Board78
Journal information78
April's reviewers of the month64
Editorial Board61
Eve's and Adam's rib for prostate cancer screening57
Building a research profile during residency55
53
49
The European Association of Urology talent incubator: bridging competencies for holistic urological care48
Recent key papers in prostate cancer42
Author Index42
MRI, Prostate cancer diagnosis, and Artificial Intelligence; What are the implications?41
April's reviewers of the month41
A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant?40
Lower urinary tract electrical sensory assessment: a systematic review and meta‐analysis39
Comparison of the effects of extrinsic compression on the drainage performance of three ureteric stents38
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer38
Association between total prostate‐specific antigen (tPSA), free/tPSA, and prostate cancer mortality35
Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit33
Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial32
ChatGPT – Integrity: Artificial Intelligence Misuse in Medical Writing32
Age‐related PSA testing for prostate cancer: NICE recommendation 1.6.331
Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?31
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension30
Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?29
Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography (PSMA‐PET) and magnetic resonance imaging (MRI) to improve diagnosis of pros29
Efficacy of RestoreX after prostatectomy: open‐label phase of a randomised controlled trial28
0.063213109970093